J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
SEPTEMBER 6, 2023
IBM disclosed "unauthorized access" to J&J’s Janssen CarePath patient assistance program, which helped over 1 million U.S. patients last year.
program 
334 
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Fierce Pharma
OCTOBER 2, 2023
. | Two days after filing a lawsuit questioning the constitutionality of drug-price negotiations in the Inflation Reduction Act, Novo Nordisk has grudgingly signed on to the program. Chamber of Commerce attempt to block the start of the program. In addition, an Ohio court rejected a U.S.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Ferring begins bladder cancer gene therapy rollout through focused program
Fierce Pharma
SEPTEMBER 13, 2023
After securing approval at the end of last year for a potential alternative to bladder removal in certain bladder cancer patients, Ferring Pharmaceuticals has given the gene therapy Adstiladrin to | While it scales up manufacturing, the company is rolling out its Adstiladrin through an early, focused program at certain clinics.
BioMarin testing programs for 2 top-selling drugs under scrutiny from DOJ
Fierce Pharma
FEBRUARY 27, 2024
Department of Justice in response to a subpoena which requested information on the company’s government-sponsored testing programs for enzyme replacement therapies Vimizim and Naglazyme. BioMarin has provided documents to the U.S. BioMarin has provided documents to the U.S.
The ABM Benchmark Survey
Advertiser: ZoomInfo
In a recent survey with Demand Gen Report, we found 59% of experienced practitioners (those with ABM programs more than a year old) indicated their ABM programs are meeting or greatly exceeding their expectations, while only 45% of novices (those with ABM programs less than one year old) could say the same.
Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.
Embracing Personalization in Biopharma Patient Support Programs
Fierce Pharma
APRIL 18, 2023
Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48
The 5 Stages of Account-Based Marketing — and How to Win Them All
Advertiser: ZoomInfo
But none of this is possible without the most important element of a successful ABM program: good data. Running an ABM program on data you don’t trust means wasted time, resources, and lost revenue. The benefits of account-based marketing are clear: internal alignment, shorter sales cycles, higher conversion rates.
ABM Evolution: How Top Marketers Are Using Account-Based Strategies
Advertiser: ZoomInfo
Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue.
4 Data-Driven Steps To Drive Successful B2B Demand Generation
Advertiser: ZoomInfo
In this eBook, you’ll discover how to improve your demand generation program—and your bottom line—in four data-driven steps: Nail down your ideal customer profile (ICP). Whether you’re stepping into a new position or you’re new to demand generation, learning the tricks of the trade can be, well, tricky. Leverage intent data.
What We Learned From Our Own Data-Driven ABM Strategy
Advertiser: ZoomInfo
talking points, we thought it would be more helpful to examine an ABM program that ZoomInfo executed. So, what does ABM look like in 2022? Instead of wading through a series of vague “how-to kick-start your ABM strategy!” In just 90 days, we were able to increase our pipeline by 114% and the customer base for this particular product by 30%.
3 Mistakes Organizations Make While Developing ABM Programs
Advertiser: ZoomInfo
While B2B research suggests organizations are thriving through successful ABM programs, getting just one campaign off the ground is more difficult than it seems. Download ZoomInfo’s latest eBook to learn about the three most common mistakes organizations make while executing an ABM program, including: Poor account selection process.
Let's personalize your content